Methotrexate and misoprostol for early abortion: A multicenter trial. I. Safety and efficacy

Contraception

Volumn 53, Issue 6, 1996, Pages 321-327

  Creinin, Mitchell D ^a,d   Vittinghoff, Eric ^b   Keder, Lisa ^a   Darney, Philip D ^b   Tiller, George ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Women's Health Care Services   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

abortion; methotrexate; misoprostol; prostaglandin

Indexed keywords

ABORTIVE AGENT; CODEINE PHOSPHATE; IBUPROFEN; METHOTREXATE; MISOPROSTOL; PARACETAMOL;

ADULT; ARTICLE; CHILL; CLINICAL PROTOCOL; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HOT FLUSH; HUMAN; INDUCED ABORTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MOUTH ULCER; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; TREATMENT FAILURE; VAGINA BLEEDING; VERTIGO; VOMITING;

EID: 0030028245     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00080-7     Document Type: Article

References (14)

1. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339-48.
2. Creinin MD, Vittinghoff E. Methotrexate and misoprostol versus misoprostol alone for early abortion: a randomized controlled trial. JAMA 1994;272:1190-5.
3. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol 3 and 7 days following methotrexate for early abortion. Am J Obstet Gynecol 1995;173:1578-84.
4. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. New Engl J Med 1995;333:537-40.
5. Schaff EA, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995;4:774-9.
6. Goldstein S. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Obstet Gynecol 1991;165:497-501.
7. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. St. Louis:C.V. Mosby Company, 1989; 378.
8. Lemeshow S, Hosmer DW. Applied Logistic Regression. New York: John Wiley & Sons, Inc., 1989.
9. Bugalho A, Bique C, Almeida L, Faundes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993;24:319-23.
10. Jain JK, Mishell DR Jr. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. New Engl J Med 1994;331: 290-3.
11. Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993;168: 1759-65.
12. Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 1992;99:1004-7.
13. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328:1509-13.
14. Creinin MD, Park M. Acceptability of medical abortion with methotrexate and misoprostol. Contraception 1995;52:41-4.